LON:SISScience in Sport Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Science in Sport PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 32.50 0.00 (0.00 %) (As of 07/3/2020 04:00 PM ET) Add Compare Share Today's Range 30.60Now: GBX 32.50▼ 32.9550-Day Range 31MA: GBX 33.09▼ 3752-Week Range 27Now: GBX 32.50▼ 64.75Volume238,330 shsAverage Volume29,236 shsMarket Capitalization£43.91 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsInsider TradesHeadlines Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes and sports enthusiasts under the SiS brand name in the United Kingdom, rest of the European Union, Australia, and internationally. Its principal product range SiS GO energy powders, isotonic gels, energy bars and hydration tablets; and SiS REGO, a range of spectrum recovery products; and WHEY20, a protein product. The company sells its products through independent sports retailers, grocers, high street chains, and third-party online retailers, and international sales distributors, as well as e-commerce platform. Science in Sport plc was founded in 1992 and is based in London, the United Kingdom.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingScience in Sport has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of GBX 80, Science in Sport has a potential upside of 146.2% from its current price of GBX 32.50.Amount of Analyst CoverageScience in Sport has only been the subject of 1 research reports in the past 90 days. Previous Next 2.9 Community Rank Outperform VotesScience in Sport has received 130 “outperform” votes. (Add your “outperform” vote.)Underperform VotesScience in Sport has received 98 “underperform” votes. (Add your “underperform” vote.)Community SentimentScience in Sport has received 57.02% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Science in Sport and other stocks. Vote “Outperform” if you believe SIS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SIS will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldScience in Sport does not currently pay a dividend.Dividend GrowthScience in Sport does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Science in Sport insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Science in Sport is -7.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Science in Sport is -7.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioScience in Sport has a P/B Ratio of 0.87. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.41 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolLON:SIS Previous Symbol CUSIPN/A CIKN/A Webwww.scienceinsport.com Phone+44-1282-440980Debt Debt-to-Equity Ratio2.39 Current Ratio2.16 Quick Ratio1.47Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£50.57 million Price / Sales0.87 Cash FlowGBX 4.33 per share Price / Cash Flow7.50 Book ValueGBX 37.40 per share Price / Book0.87Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares135,100,992Market Cap£43.91 million Next Earnings DateN/A OptionableNot Optionable LSE:SIS Rates by TradingView Receive SIS News and Ratings via Email Sign-up to receive the latest news and ratings for SIS and its competitors with MarketBeat's FREE daily newsletter. Science in Sport (LON:SIS) Frequently Asked Questions How has Science in Sport's stock been impacted by COVID-19 (Coronavirus)? Science in Sport's stock was trading at GBX 41 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SIS shares have decreased by 20.7% and is now trading at GBX 32.50. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Science in Sport? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Science in Sport in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Science in Sport. How were Science in Sport's earnings last quarter? Science in Sport PLC (LON:SIS) issued its earnings results on Wednesday, March, 21st. The company reported ($7.70) earnings per share for the quarter, beating analysts' consensus estimates of ($8.20) by $0.50. The business had revenue of $15.62 million for the quarter. View Science in Sport's earnings history. What price target have analysts set for SIS? 1 equities research analysts have issued 12-month price objectives for Science in Sport's shares. Their forecasts range from GBX 80 to GBX 80. On average, they expect Science in Sport's share price to reach GBX 80 in the next twelve months. This suggests a possible upside of 146.2% from the stock's current price. View analysts' price targets for Science in Sport. Has Science in Sport been receiving favorable news coverage? Media coverage about SIS stock has trended negative this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Science in Sport earned a daily sentiment score of -2.8 on InfoTrie's scale. They also gave news stories about the company a news buzz of 7.0 out of 10, indicating that recent news coverage is likely to have an effect on the stock's share price in the next few days. View the latest news about Science in Sport. Who are some of Science in Sport's key competitors? Some companies that are related to Science in Sport include ESSA Pharma (EPI), Probiotec (PBP), Green Organic Dutchman (TGOD), Shield Therapeutics (STX), WeedMD (WMD), cbdMD (YCBD), Althea Group (AGH), Supreme Cannabis (FIRE), Delta 9 Cannabis (NINE), Flowr (FLWR), Venture Life Group (VLG), Biosyent (RX), Acerus Pharmaceuticals (ASP), MMJ Group (MMJ) and Auscann Group (AC8). View all competitors. What other stocks do shareholders of Science in Sport own? Based on aggregate information from My MarketBeat watchlists, some companies that other Science in Sport investors own include Cidara Therapeutics (CDTX), Carnival (CCL), Bellway (BWY), British American Tobacco (BTI), Boohoo Group (BOO), B&M European Value Retail (BME), Balfour Beatty (BBY), Alibaba Group (BABA), Advanced Oncotherapy (AVO) and ASOS (ASC). Who are Science in Sport's key executives? Science in Sport's management team includes the following people: Mr. Stephen N. Moon, CEO & Exec. DirectorMs. Elizabeth J. Lake, CFO & Exec. Director (Age 51)Dr. James Morton, Group Chief Scientific Officer What is Science in Sport's stock symbol? Science in Sport trades on the London Stock Exchange (LON) under the ticker symbol "SIS." How do I buy shares of Science in Sport? Shares of SIS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Science in Sport's stock price today? One share of SIS stock can currently be purchased for approximately GBX 32.50. How big of a company is Science in Sport? Science in Sport has a market capitalization of £43.91 million and generates £50.57 million in revenue each year. What is Science in Sport's official website? The official website for Science in Sport is www.scienceinsport.com. How can I contact Science in Sport? Science in Sport's mailing address is 16-18 Hatton Garden, LONDON, EC1N 8AT, United Kingdom. The company can be reached via phone at +44-1282-440980. This page was last updated on 7/4/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
